IRulya Therapeutics Inc. (IRLA) Net Income by Year
IRulya Therapeutics Inc. reported a net loss of $84.0M in fiscal year 2025. This represents a decrease of 47.8% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters IRulya Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IRLA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IRLA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More IRulya Therapeutics Inc. financials
Frequently Asked Questions
What was IRulya Therapeutics Inc.'s net income in fiscal year 2025?
IRulya Therapeutics Inc. reported a net loss of $84.0M in fiscal year 2025.
How fast is IRulya Therapeutics Inc.'s net income growing?
IRulya Therapeutics Inc. (IRLA) net income fell by 47.8% year over year, from -$56.8M to -$84.0M in fiscal year 2025.
How has IRulya Therapeutics Inc.'s net income changed over the years?
Across the 8 fiscal years this page covers, IRulya Therapeutics Inc. (IRLA) net income went from -$12.5M in fiscal year 2018 to -$84.0M in fiscal year 2025.
What was IRulya Therapeutics Inc.'s net income in the most recent quarter?
IRulya Therapeutics Inc. (IRLA) reported -$75.5M in net income in Q2 2026. This represents a decrease of 370.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what IRulya Therapeutics Inc. (IRLA) reported on that line in every period on record.